Headache
Headache

DFN-15 (Celecoxib Oral Solution, 25 Mg/ml) in the Acute Treatment of Episodic Migraine: Efficacy Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies

book_2 Source: AHSAM 2020 - Oral session Published on October 2, 2020 | NEW
calendar_today Published on Medfyle: July 2020
import_contacts 7 min
headphones 4 min

In this medfyle

Expert commentary by by A. Laine Green, MSc, MD, FRCPC, FAHS

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Acknowledgements
Read more arrow_downward Hide arrow_upward

This is a highlights summary of an oral session given at the AHSAM 2020 Virtual Annual Scientific Meeting and presented by:

Sagar Munjal, MD
Vice President- Clinical development and medical affairs
Dr Reddys Inc Princeton, New Jersey

The content is produced by Infomedica, the official reporting partner of ASHAM 2020 Virtual Annual Scientific Meeting. The summary text was drafted by Goldcrest Medical Writing, reviewed by Marco Vercellino, MD, an independent external expert, and approved by Jessica Ailani, MD, FAHS and Mark J. Burish, MD, PhD, the scientific editors of the program.

The presenting authors of the original session had no part in the creation of this conference highlights summary.

In addition, an expert commentary on the topic has been provided by:

A. Laine Green, MSc, MD, FRCPC, FAHS
Assistant Professor and Staff Physician
Department of Neurology
Dartmouth Headache Center
Geisel School of Medicine at Dartmouth

About the Expert
Read more arrow_downward Hide arrow_upward

A. Laine Green, MSc, MD, FRCPC, FAHS
Assistant Professor and Staff Physician
Department of Neurology
Dartmouth Headache Center
Geisel School of Medicine at Dartmouth

Dr. A. Laine Green is from Halifax Nova Scotia. His undergraduate degree was focused in organic chemistry. He then received a Master’s degree in synthetic (mechanistic) organic chemistry from Queen’s University. He completed his Medical School and Neurology residency training at Dalhousie University in Halifax. He completed his headache medicine fellowship with Dr. David Dodick at the Mayo Clinic in Arizona. His first year of fellowship was on the University of Arizona Campus in Tucson in the lab of Dr. Frank Porreca completing a preclinical project in medication overuse and cortical spreading depression. His second year of fellowship was the clinical based year with Dr. Dodick in Scottsdale. After fellowship Laine returned to Halifax where he was an Assistant Professor with the Division of Neurology at Dalhousie University for 5 years.  In late 2019 he moved to Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth where he is an Assistant Professor in the Department of Neurology.


Feedback